Vadastuximab talirine (SGN-CD33A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vadastuximab talirine (SGN-CD33A), covering 2018-12-21 to 2018-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS [Phase 1, Phase 2]